Merck & Co Stock

Merck & Co Dividend

The Dividend of Merck & Co (MRK) as of Aug 6, 2026 is 3.28 USD. In the previous year, Dividend was 3.12 USD — a change of 5.13% (higher).

Dividend

3.28USD

YoY

5.13%

Dividend yield

2.56 %

Last updated:

How much dividend does Merck & Co 2026 pay?

According to the latest status from August 2026, Merck & Co paid a total of 3.28 USD per share in dividends within the last 12 months. With the current Merck & Co price of 128.00 USD, this corresponds to a dividend yield of 2.52 %. A dividend is paid times per year.

Merck & Co currently offers a dividend yield of about 2.56%. The payout ratio is around 45% of earnings. The dividend has grown at 4.1% per year over the past 19 years.

Historical Merck & Co Dividends

A dividend is paid times per year. Last year, the payout months were January, April, July and October.

PaydateDividend
4/16/20260.85USD
1/15/20260.85USD
10/15/20250.81USD
7/16/20250.81USD
4/17/20250.81USD
1/16/20250.81USD
10/16/20240.77USD
7/17/20240.77USD
4/14/20240.77USD
1/14/20240.77USD
10/14/20230.73USD
7/14/20230.73USD
4/14/20230.73USD
1/14/20230.73USD
10/14/20220.69USD
7/14/20220.69USD
4/14/20220.69USD
1/14/20220.69USD
10/14/20210.65USD
7/14/20210.65USD
...

Merck & Co dividend history and estimates

In 2025, Merck & Co paid a dividend amounting to 3.28 USD. Dividend means that Merck & Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
2.64 USD
0.00 USD
Jan 1, 2022
2.80 USD
0.00 USD
Jan 1, 2023
2.96 USD
0.00 USD
Jan 1, 2024
3.12 USD
0.00 USD
Jan 1, 2025
3.28 USD
0.00 USD
Jan 1, 2026 (e)
0.85 USD
2.55 USD
Jan 1, 2027 (e)
0.00 USD
3.60 USD
Jan 1, 2028 (e)
0.00 USD
3.80 USD

Is the Merck & Co Dividend Safe?

Merck & Co has been increasing the dividend for 15 years.

Over the past 10 years, Merck & Co has increased it by an annual 6.13%.

Over a five-year period, the distribution rose by 5.75%.

Analysts expect a Dividend Increase of 1.81% for the current fiscal year.

Merck & Co dividend payout ratio

In 2025, Merck & Co had a payout ratio of 44.71%. The payout ratio indicates the percentage of the company's profits that Merck & Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
51.29 %
Jan 1, 2022
49.14 %
Jan 1, 2023
2,071.32 %
Jan 1, 2024
46.32 %
Jan 1, 2025
44.71 %
Jan 1, 2026 (e)
122.45 %
Jan 1, 2027 (e)
37.45 %
Jan 1, 2028 (e)
35.90 %

Dividend Details

Understanding Merck & Co's Dividend Distributions

Merck & Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Merck & Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Merck & Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Merck & Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Merck & Co Stock analysis

What does Merck & Co do? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck & Co stock

Over the past 12 months, Merck & Co paid a dividend of 3.28 USD . This corresponds to a dividend yield of about 2.56 %. For the coming 12 months, Merck & Co is expected to pay a dividend of 3.60 USD.

The current dividend yield of Merck & Co is 2.56 %.

Merck & Co pays a dividend, distributed in the months of , , , .

Merck & Co paid dividends every year for the past 36 years.

For the upcoming 12 months, dividends amounting to 3.60 USD are expected. This corresponds to a dividend yield of 2.76 %.

Merck & Co is assigned to the 'Health' sector.

To receive the latest dividend of Merck & Co from amounting to 0.85 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Merck & Co distributed 3.12 USD as dividends.

The dividends of Merck & Co are distributed in USD.

Dividend calendar 2026
Access this data via the Eulerpool API
Get Free API Key

All Key Metrics — Merck & Co